Bg pattern

BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE)

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE)

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Bemrist Breezhaler 125 micrograms/62.5 micrograms inhalation powder (hard capsule)

Bemrist Breezhaler 125 micrograms/127.5 micrograms inhalation powder (hard capsule)

Bemrist Breezhaler 125 micrograms/260 micrograms inhalation powder (hard capsule)

indacaterol/mometasone furoate

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Bemrist Breezhaler is and what it is used for
  2. What you need to know before you use Bemrist Breezhaler
  3. How to use Bemrist Breezhaler
  4. Possible side effects
  5. Storing Bemrist Breezhaler
  6. Contents of the pack and other information

Instructions for using the Bemrist Breezhaler inhaler

1. What Bemrist Breezhaler is and what it is used for

What Bemrist Breezhaler is and how it works

Bemrist Breezhaler contains two active substances called indacaterol and mometasone furoate.

Indacaterol belongs to a group of medicines called bronchodilators. It relaxes the muscles of the small airways in the lungs. This helps to open up the airways and makes it easier to breathe in and out. When used regularly, it helps to keep the small airways in the lungs open.

Mometasone furoate belongs to a group of medicines called corticosteroids (or steroids). Corticosteroids reduce the swelling and irritation (inflammation) of the small airways in the lungs and in this way gradually relieve breathing problems. Corticosteroids also help to prevent asthma attacks.

What Bemrist Breezhaler is used for

Bemrist Breezhaler is used as a regular treatment for asthma in adults and adolescents (12 years of age and older).

Asthma is a serious, chronic lung disease in which the muscles around the smaller airways tighten (bronchoconstriction) and become inflamed. The symptoms come and go and include difficulty breathing, wheezing, chest tightness, and coughing.

You should use Bemrist Breezhaler every day as directed by your doctor and not just when you have breathing problems or other asthma symptoms. This will help to keep your asthma under control. Do not use this medicine to relieve a sudden attack of shortness of breath or wheezing.

Ask your doctor if you have any questions about how Bemrist Breezhaler works or why you have been prescribed this medicine.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Bemrist Breezhaler

Follow your doctor's instructions carefully.

Do not use Bemrist Breezhaler

  • if you are allergic to indacaterol, mometasone furoate, or any of the other ingredients of this medicine (listed in section 6). If you think you may be allergic, consult your doctor.

Warnings and precautions

Talk to your doctor, pharmacist, or nurse beforeusing Bemrist Breezhaler if any of the following apply to you:

  • if you have heart problems including a fast or irregular heartbeat,
  • if you have thyroid problems,
  • if you have been told you have diabetes or high blood sugar levels,
  • if you have seizures or fits,
  • if you have low potassium levels in your blood,
  • if you have severe kidney problems,
  • if you have pulmonary tuberculosis (TB) or any other long-standing or untreated infection.

During treatment with Bemrist Breezhaler

Stop using this medicine and seek medical help immediatelyif you experience any of the following:

  • chest tightness, cough, wheezing, or difficulty breathing immediately after using Bemrist Breezhaler (signs that the medicine has unexpectedly constricted the airways, known as paradoxical bronchospasm),
  • difficulty breathing or swallowing, swelling of the tongue, lips, or face, skin rash, itching, and hives (signs of an allergic reaction).

Children and adolescents

Do not give this medicine to children under 12 years of age as it has not been studied in this age group.

Other medicines and Bemrist Breezhaler

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. In particular, tell your doctor or pharmacist if you are using:

  • medicines that lower the amount of potassium in the blood. These include diuretics (which increase urine production and may be used to treat high blood pressure, e.g., hydrochlorothiazide), other bronchodilators such as methylxanthines used for respiratory disorders (e.g., theophylline), or corticosteroids (e.g., prednisolone).
  • tricyclic antidepressants or monoamine oxidase inhibitors (medicines used to treat depression).
  • any medicine that may be similar to Bemrist Breezhaler (containing similar active substances); as their use together may increase the risk of side effects.
  • medicines called beta-blockers which may be used for high blood pressure or other heart problems (such as propranolol), or to treat glaucoma (e.g., timolol).
  • ketoconazole or itraconazole (medicines used to treat fungal infections).
  • ritonavir, nelfinavir, or cobicistat (medicines used to treat HIV infection).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before using this medicine. Your doctor will decide whether you can use Bemrist Breezhaler.

Driving and using machines

This medicine is unlikely to affect your ability to drive or use machines.

Bemrist Breezhaler contains lactose

This medicine contains approximately 25 mg of lactose per capsule. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

3. How to use Bemrist Breezhaler

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Follow the instructions for administration of this medicine given by your doctor or pharmacist carefully. If you are in doubt, consult your doctor or pharmacist again.

How much Bemrist Breezhaler to inhale

There are three different doses of Bemrist Breezhaler capsules. Your doctor will decide which one is best for you.

The usual dose is to inhale the contents of one capsule each day. You only need to inhale the medicine once a day. Do not use more doses than your doctor has prescribed.

You should use Bemrist Breezhaler every day, even if your asthma is not bothering you.

When to inhale Bemrist Breezhaler

Inhale Bemrist Breezhaler at the same time each day. This will help you control your symptoms throughout the day and night. It will also help you remember to use it.

How to inhale Bemrist Breezhaler

  • Bemrist Breezhaler is for inhalation use only.
  • In this pack, you will find an inhaler and capsules that contain the medicine. The inhaler allows you to inhale the medicine from the capsule. Use the capsules only with the inhaler provided in this pack. The capsules should be kept in the blister pack until you need to use them.
  • Peel back the foil to open the blister pack, do not push the capsule through the foil.
  • When starting a new pack, use the new inhaler provided in the pack.
  • Discard the inhaler from each pack once you have used all the capsules.
  • Do not swallow the capsules.
  • For more information on how to use the inhaler, please read the instructions at the end of this leaflet.

If your symptoms do not improve

If your asthma does not improve or even gets worse after you have started using Bemrist Breezhaler, talk to your doctor.

If you use more Bemrist Breezhaler than you should

If you accidentally inhale too much of this medicine, contact your doctor or hospital immediately. Medical attention may be needed.

If you forget to use Bemrist Breezhaler

If you miss a dose at the usual time, inhale it as soon as you can on that day. Then, the next day, inhale the next dose at the usual time. Do not inhale two doses on the same day.

If you stop using Bemrist Breezhaler

Do not stop using Bemrist Breezhaler unless your doctor tells you to. Your asthma symptoms may come back if you stop using it.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some side effects may be serious

Stop using Bemrist Breezhaler and seek medical help immediately if you experience any of the following:

Common:may affect up to 1 in 10 people

  • difficulty breathing or swallowing, swelling of the tongue, lips, or face, skin rash, itching, and hives (signs of an allergic reaction).

Uncommon:may affect up to 1 in 100 people

  • swelling of the tongue, lips, face, or throat (possible signs of angioedema)

Other side effects

The following is a list of other side effects. If these side effects become serious, please talk to your doctor, pharmacist, or nurse.

Very common:may affect more than 1 in 10 people

  • throat pain
  • nasal discharge
  • sudden difficulty breathing and feeling of chest tightness with wheezing or coughing

Common:may affect up to 1 in 10 people

  • voice changes (hoarseness)
  • nasal congestion
  • sneezing, cough
  • headache
  • pain in the muscles, bones, or joints (signs of musculoskeletal pain)

Uncommon:may affect up to 1 in 100 people

  • fast heartbeat
  • mouth sores (signs of oral candidiasis)
  • high blood sugar levels
  • muscle spasms
  • itching
  • skin rash
  • clouding of the lenses of your eyes (signs of cataract)
  • blurred vision

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Bemrist Breezhaler

  • Keep this medicine out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the carton and blister after ‘EXP’. The expiry date refers to the last day of that month.
  • Do not store above 30°C.
  • Store the capsules in the original blister pack to protect them from light and moisture and do not remove them until just before use.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and additional information

Composition of Bemrist Breezhaler

  • The active substances are indacaterol (as acetate) and mometasone furoate.

Bemrist Breezhaler 125 micrograms/62.5 micrograms

Each capsule contains 173 micrograms of indacaterol as acetate (equivalent to 150 micrograms of indacaterol) and 80 micrograms of mometasone furoate. The delivered dose (the dose that is released from the inhaler mouthpiece) is equivalent to 125 micrograms of indacaterol and 62.5 micrograms of mometasone furoate.

Bemrist Breezhaler 125 micrograms/127.5 micrograms

Each capsule contains 173 micrograms of indacaterol as acetate (equivalent to 150 micrograms of indacaterol) and 160 micrograms of mometasone furoate. The delivered dose (the dose that is released from the inhaler mouthpiece) is equivalent to 125 micrograms of indacaterol and 127.5 micrograms of mometasone furoate.

Bemrist Breezhaler 125 micrograms/260 micrograms

Each capsule contains 173 micrograms of indacaterol as acetate (equivalent to 150 micrograms of indacaterol) and 320 micrograms of mometasone furoate. The delivered dose (the dose that is released from the inhaler mouthpiece) is equivalent to 125 micrograms of indacaterol and 260 micrograms of mometasone furoate.

  • The other component of the powder for inhalation is (see the section “Bemrist Breezhaler contains lactose” in section 2).

Appearance and pack contents

In this pack, you will find an inhaler together with capsules in blisters. The capsules are transparent and contain a white powder.

  • The Bemrist Breezhaler 125 micrograms/62.5 micrograms capsules have a product code “IM150-80” printed in blue above a blue bar on the body and the logo printed in blue and surrounded by two blue bars on the cap.
  • The Bemrist Breezhaler 125 micrograms/127.5 micrograms capsules have a product code “IM150-160” printed in grey on the body and a logo printed in grey on the cap.
  • The Bemrist Breezhaler 125 micrograms/260 micrograms capsules have a product code “IM150-320” printed in black above two black bars on the body and a logo printed in black and surrounded by two black bars on the cap.

The following pack sizes are available:

Single pack containing 10 x 1 or 30 x 1 hard capsules, together with 1 inhaler.

Multiple packs containing 3 boxes, each with 30 x 1 capsules together with 3 inhalers.

Multiple packs containing 15 boxes, each with 10 x 1 capsules together with 1 inhaler.

Not all pack sizes may be marketed.

Marketing authorisation holder

Novartis Europharm Limited

Vista Building

Elm Park, Merrion Road

Dublin 4

Ireland

Manufacturer

Novartis Farmacéutica, S.A.

Gran Via de les Corts Catalanes, 764

08013 Barcelona

Spain

Novartis Pharma GmbH

Roonstraße 25

D-90429 Nuremberg

Germany

Novartis Pharma GmbH

Sophie-Germain-Strasse 10

90443 Nürnberg

Germany

You can request more information about this medicine from the local representative of the marketing authorisation holder:

Belgium

Novartis Pharma N.V.

Tel: +32 2 246 16 11

Lithuania

SIA Novartis Baltics Lietuvos filialas

Tel: +370 5 269 16 50

Bulgaria

Novartis Bulgaria EOOD

Tel: +359 2 489 98 28

Luxembourg

Novartis Pharma N.V.

Tel: +32 2 246 16 11

Czech Republic

Novartis s.r.o.

Tel: +420 225 775 111

Hungary

Novartis Hungária Kft.

Tel: +36 1 457 65 00

Denmark

Novartis Healthcare A/S

Tel: +45 39 16 84 00

Malta

Novartis Pharma Services Inc.

Tel: +356 2122 2872

Germany

Novartis Pharma GmbH

Tel: +49 911 273 0

Netherlands

Novartis Pharma B.V.

Tel: +31 88 04 52 111

Estonia

SIA Novartis Baltics Eesti filiaal

Tel: +372 66 30 810

Norway

Novartis Norge AS

Tel: +47 23 05 20 00

Greece

Novartis (Hellas) A.E.B.E.

Tel: +30 210 281 17 12

Austria

Novartis Pharma GmbH

Tel: +43 1 86 6570

Spain

Laboratorios Gebro Pharma, S.A.

Tel: +34 93 205 86 86

Poland

Novartis Poland Sp. z o.o.

Tel: +48 22 375 4888

France

Novartis Pharma S.A.S.

Tel: +33 1 55 47 66 00

Portugal

Novartis Farma - Produtos Farmacêuticos, S.A.

Tel: +351 21 000 8600

Croatia

Novartis Hrvatska d.o.o.

Tel: +385 1 6274 220

Romania

Novartis Pharma Services Romania SRL

Tel: +40 21 31299 01

Ireland

Novartis Ireland Limited

Tel: +353 1 260 12 55

Slovenia

Novartis Pharma Services Inc.

Tel: +386 1 300 75 50

Iceland

Vistor hf.

Tel: +354 535 7000

Slovakia

Novartis Slovakia s.r.o.

Tel: +421 2 5542 5439

Italy

Novartis Farma S.p.A.

Tel: +39 02 96 54 1

Finland

Novartis Finland Oy

Tel: +358 (0)10 6133 200

Cyprus

Novartis Pharma Services Inc.

Tel: +357 22 690 690

Sweden

Novartis Sverige AB

Tel: +46 8 732 32 00

Latvia

SIA Novartis Baltics

Tel: +371 67 887 070

United Kingdom(Northern Ireland)

Novartis Ireland Limited

Tel: +44 1276 698370

Date of last revision of this leaflet:

Other sources of information

Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.

Instructions for use of the Bemrist Breezhaler inhaler

Please read the complete Instructions for Use of the Bemrist Breezhaler inhaler before using it.

Hand holding an applicator with a covered needle and inserting it into a white and grey circular device

Hand holding a white inhaler with curved arrows indicating the direction of inhalation and an orange button

Needle inserted into the skin at an upward angle and a grey arrow indicating the direction of injection

Grey inhaler device with mouthpiece and nasal chamber, connected to thin flexible tubes

Insert

Puncture and release

Inhale deeply

Check that the capsule is empty

Grey arrow pointing downwards with a white number one in the centre indicating a direction or step to follow

Grey arrow pointing downwards with a white number two in the centre of the arrow body

Grey arrow pointing downwards with a white number three superimposed in the centre

Grey arrow pointing downwards with the word

Hand pressing the plunger of an auto-injector with a black arrow indicating the direction of injection

Hand holding an auto-injector with arrows indicating the correct pressure and direction for injection

Schematic representation of subcutaneous injection showing the needle inserted at an angle and the displacement of the skin fold

Grey inhaler device with mouthpiece and nasal chamber, connected to thin flexible tubes

Step 1a:

Remove the cap

Step 2a:

Puncture the capsule once

Hold the inhaler in a vertical position.

Puncture the capsule by pressing both buttons firmly at the same time.

Step 3a:

Exhale completely

Do not blow into the inhaler.

Check that the capsule is empty

Open the inhaler to check if there is any powder left in the capsule.

If there is powder left in the capsule:

  • Close the inhaler
  • Repeat steps 3a to 3d.

Hand holding an auto-injector with the protective cover partially removed, arrow indicates direction of removal

You should hear a sound when the capsule is punctured.

Puncture the capsule only once.

Transdermal patch attached to the skin with an arrow indicating the direction of application and shaded areas around

Two cross-sections of a cartridge showing the plunger and the powder medicine

Remains powderEmpty

Step 1b:

Open the inhaler

Hand holding a white inhaler with a grey button and arrows indicating pressure on the sides

Step 2b:

Release the buttons completely

Step 3b:

Inhale the medicine deeply

Hold the inhaler as shown in the figure.

Put the mouthpiece in your mouth and close your lips firmly around it.

Do not press the buttons.

Blister strips with ten oval compartments and a separate strip with a single compartmentHand slowly removing the protective strip from a brown adhesive patch containing a white oval medicine

Inhale quickly and as deeply as possible.

During inhalation, you will hear a whirring sound.

You may notice the taste of the medicine when you inhale.

Hand turning an injection device with an exposed needle and a falling capsule

Step 1c:

Remove the capsule

Separate one of the blisters from the blister strip.

Open the blister and remove a capsule.

Do not press the capsule through the foil.

Do not swallow the capsule.

Open mouth showing the tongue and head profile with short hair and outlined neck

Step 3c:

Hold your breath

Hold your breath for 5 seconds.

Step 3d:

Rinse your mouth

Rinse your mouth with water after each dose and spit it out.

Remove the empty capsule

Discard the empty capsule in your household waste.

Close the inhaler and put the cap back on.

Hand holding an auto-injector with the protective cover partially removed, showing the exposed plunger

Step 1d:

Insert the capsule

Never put the capsule directly into the mouthpiece.

Important information

  • The Bemrist Breezhaler capsules should always be stored in the blister and removed only immediately before use.
  • To remove the capsule from the blister, do not press the capsule through the foil.
  • Do not swallow the capsule.
  • Do not use the Bemrist Breezhaler capsules with another inhaler.
  • Do not use the Bemrist Breezhaler inhaler with another medicine in capsules.
  • Never put the capsule in your mouth or in the inhaler mouthpiece.
  • Do not press the side buttons more than once.
  • Do not blow into the mouthpiece.
  • Do not press the buttons while inhaling through the mouthpiece.
  • Do not handle the capsules with wet hands.
  • Never wash your inhaler with water.

Auto-injector device with protective cover removed by an index finger, showing the activation button and directional arrow

Step 1e:

Close the inhaler

Medicine inhaler with base, mouthpiece, and capsules, arrows indicating parts and use, explanatory text about operation and disposal

Online doctors for BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE)

Discuss questions about BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE), including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80
0.0 (0)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance.

His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation.

Patients commonly consult Dr Daniel Cichi for:

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.
Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.
Camera Book a video appointment
€55
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (764)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE)?
BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE) requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE)?
The active ingredient in BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE) is indacaterol and mometasone. This information helps identify medicines with the same composition but different brand names.
How much does BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE) cost in pharmacies?
The average pharmacy price for BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE) is around 41.28 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE)?
BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE) is manufactured by Novartis Europharm Limited. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE) online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE) is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to BEMRIST BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE)?
Other medicines with the same active substance (indacaterol and mometasone) include ATECTURA BREEZHALER 125/127.5 micrograms INHALATION POWDER (HARD CAPSULE), ATECTURA BREEZHALER 125 micrograms/260 micrograms INHALATION POWDER (HARD CAPSULE), ATECTURA BREEZHALER 125 micrograms/62.5 micrograms INHALATION POWDER (HARD CAPSULE). These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media